Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
KAKALA BIO, Inc. logo

KALA BIO, Inc. (KALA)

NASDAQ Global Select · Currency in USD
$0.19 ▲ +0.00 (+2.48%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.19 ▲ +0.00 (+2.05%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$0.19
Open
$0.19
Day's Range
$0.19 – $0.20
52 Week Range
$0.11 – $95.50
Volume
204,499
Avg. Volume
1,129,127
Market Cap
$3.68M
Beta (5Y Monthly)
-2.41
PE Ratio (TTM)
--
EPS (TTM)
-$135.92
Earnings Date
Nov 10, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$18.25

Profile: KALA BIO, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
6
CEO
Avi Minkowitz
Website
kalarx.com

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases.

Earnings

Next report: Tue, Nov 10, 2026
EPS estimate -$6.00
DateEst.Actual
Aug 19, 2026-$6.00-$21.32Miss
May 15, 2026-$8.50-$0.14Beat
Apr 15, 2026-$16.00$0.08Beat
Nov 19, 2025-$50.50-$1.07Beat
Aug 8, 2025-$91.00-$85.50Beat
May 14, 2025-$101.50-$70.50Beat

Analyst view

Consensus price target
$18.25 ▲ +9,500.2%
Range $1.50 – $35.00
Rating: Hold
Buy 36% · Hold 55% · Sell 9%

Get free alerts on KALA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.